Interactive HEOR and HTA software to demonstrate value, calculate budget impact, and accelerate market access. Build confidence with payers, hospitals, and HCPs using real-world economic models.
Trusted by




















Launch of Medip Academy . Our new training platform offers six courses covering software usage and health economic principles, alongside five structured tracks to support platform mastery and day-to-day implementation.
Diagnostic AI, medtech, biotech, and pharma companies often lose momentum after clinical success because decision-makers ask a local question that global studies do not answer:
“What is the real impact for my specific organization?”
When global evidence fails to answer that local question, an impact gap appears. That gap delays adoption, weakens budget conversations, and slows market uptake.
Medip Analytics builds interactive HEOR and HTA software that translates global clinical success into local financial and operational relevance.
Discover how Medip Analytics translates clinical evidence into local value.
Medip Analytics empowers you with interactive health economic software tailored to your specific use case.
Translate global evidence into local relevance for healthcare professionals, payers, policymakers, and hospital teams.
Build budget impact models for hospitals, regions, and health systems using local assumptions.
Assess cost-effectiveness, return on investment, and value for money across the full care pathway.
Show how innovation changes workload, patient flow, capacity, and daily clinical practice.
Connect clinical and economic evidence to reimbursement, market access, and stakeholder communication.
Methodologically robust, transparent, and practical for real-world value communication.
From early-stage value framing to commercial launch, our platform supports the evidence your stakeholders need at every step.
Surface early clinical value propositions that resonate with KOLs and HCPs. Identify which outcomes, costs, and workflow changes matter most to your first adopters.
Key outputs
Stakeholders
Optimize value by calculating optimal thresholds and innovation costs. Build the health economic case alongside clinical development so evidence gaps are addressed early.
Key outputs
Stakeholders
Lead with HCP-ready views: outcomes, workflow, and budget impact by ward and service. Translate global evidence into the specific local story each decision-maker needs.
Key outputs
Stakeholders
Talk to an expert
Get a practical walkthrough of how to demonstrate clinical, operational, and economic value for diagnostic AI, medtech, biotech, and pharma products.
We build a single, robust health economic engine for your product. Then, we provide tailored interfaces so your entire team—from economists to MSLs—can speak the same language of value.
Full access to deep-dive HEOR models, budget thresholds, and scenario testing to build the robust evidence base.
Translates complex algorithms into clear clinical impact visuals for engaged KOL and clinician conversations.
Equipped to demonstrate country- and region-specific cost-effectiveness to payers and policymakers.
Simplified, interactive views to rapidly show hospital budget impact and drive local adoption.
Medip Analytics is a health economic software company for diagnostic AI, medtech, biotech, and pharma. We build interactive HEOR and HTA software for value demonstration, budget impact, market access, payer evidence, and stakeholder engagement.
The platform supports cost-effectiveness analysis, budget impact, return on investment, hospital workflow impact, payer evidence, and stakeholder-specific value communication.
It is designed for diagnostic AI, diagnostics, medtech, biotech, and pharma teams that need to prove clinical, operational, and economic value to hospitals, payers, policymakers, and commercial teams.
Medip Analytics is based in Nijmegen, The Netherlands. The company is led by Tim Govers, PhD, CEO and HTA expert, and Stan Wijn, PhD, CTO and modeling and software expert.
Personal consultation
Speak directly with our team about HEOR, HTA, budget impact, market access, and value demonstration for diagnostic AI, medtech, biotech, and pharma.